Home  >  Products  >  Map2k1 (mitogen-activated protein kinase kinase 1 ) Blocking Peptide (the N terminal of Map2k1)(100ug)
Map2k1 (mitogen-activated protein kinase kinase 1 ) Blocking Peptide (the N terminal of Map2k1)(100ug)

Map2k1 (mitogen-activated protein kinase kinase 1 ) Blocking Peptide (the N terminal of Map2k1)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Map2k1 Antibody (ARP61081_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP61081
Size: 100ug
Weight: 43kDa
Gene: 26395
Format: Lyophilized powder
Target: Map2k1 is a dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway.Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation.
Alternative names: MAPKK1; MEKK1; Mek1; Prkmk1